The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions
Universidade do Porto · Josep Carreras Leukaemia Research Institute · +6 more institutions
Abstract
Dysregulated microglia activation, leading to neuroinflammation, is crucial in neurodegenerative disease development and progression. We constructed an atlas of human brain immune cells by integrating nineteen single-nucleus RNA-seq and single-cell RNA-seq datasets from multiple neurodegenerative conditions, comprising 241 samples from patients with Alzheimer’s disease, autism spectrum disorder, epilepsy, multiple sclerosis, Lewy body diseases, COVID-19, and healthy controls. The integrated Human Microglia Atlas (HuMicA) included 90,716 nuclei/cells and revealed nine populations distributed across all conditions. We identified four subtypes of disease-associated microglia and disease-inflammatory macrophages,…
Citation impact
- FWCI
- 47.54
- Percentile
- 100%
- References
- 70
Authors
9- RMRicardo Martins-Ferreira
Universidade do Porto, Josep Carreras Leukaemia Research Institute
- JCJosep Calafell-Segura
Josep Carreras Leukaemia Research Institute
- BLBárbara Leal
Universidade do Porto
- JRJavier Rodríguez‐Ubreva
Josep Carreras Leukaemia Research Institute
- EMElena Martínez‐Sáez
Universitat Autònoma de Barcelona
Topics & keywords
- Microglia
- Neuroscience
- Atlas (anatomy)
- Disease
- Biology
- Medicine
- Immunology
- Pathology
Funding
- CDCentres de Recerca de CatalunyaAwards: 501100011033, MCIN/AEI/10.13039/501100011033
- ECEuropean CommissionAwards: 10.13039/501100011033, 13039/501100011033, 501100011033, AEI/10.13039/501100011033, MCIN/AEI/10.13039/501100011033
- GDGeneralitat de CatalunyaAwards: 10.13039/501100011033, 501100011033, MCIN/AEI/10.13039/501100011033
- MDMinisterio de Ciencia e InnovaciónAwards: MCIN/AEI/10, 10.13039, AEI/10.13039/501100011033, PID2020117212RB-I00, 501100011033, AEI/10, MCIN/AEI/10., MCIN/AEI/10.13039/501100011033, 10.13039/501100011033, 13039/501100011033, RYC2021, /AEI/10.13039/501100011033, MCIN/AEI/10.13039
- FIFundació Institut de Recerca Hospital Universitari Vall d’Hebron
- CDCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
- FPFundação para a Ciência e a TecnologiaAwards: MCIN/AEI/10.13039/501100011033, LA/P/006/2020, UIDB/00215/2020, UIDP/00215/2020
- ADAgència de Gestió d'Ajuts Universitaris i de RecercaAwards: 10.13039/501100011033, 13039/501100011033, MCIN/AEI/10.13039/501100011033
- IDInstituto de Salud Carlos IIIAwards: MCIN/AEI/10.13039/501100011033, /10.13039/501100011033, PI21/01603, AEI/10.13039/501100011033
- AEAgencia Estatal de InvestigaciónAwards: AEI/10.13039/501100011033, 501100011033, 10.13039/501100011033, MCIN/AEI/10.13039/501100011033, 13039, 10.13039, AEI/10, 13039/501100011033, AEI/10.
- IDInstituto de Ciências Biomédicas Abel Salazar, Universidade do Porto
- IDInstitut de Recerca contra la Leucèmia Josep Carreras